Unknown

Dataset Information

0

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces.


ABSTRACT: BACKGROUND:Detection of new drug-target interactions by computational algorithms is of crucial value to both old drug repositioning and new drug discovery. Existing machine-learning methods rely only on experimentally validated drug-target interactions (i.e., positive samples) for the predictions. Their performance is severely impeded by the lack of reliable negative samples. RESULTS:We propose a method to construct highly-reliable negative samples for drug target prediction by a pairwise drug-target similarity measurement and OCSVM with a high-recall constraint. On one hand, we measure the pairwise similarity between every two drug-target interactions by combining the chemical similarity between their drugs and the Gene Ontology-based similarity between their targets. Then we calculate the accumulative similarity with all known drug-target interactions for each unobserved drug-target interaction. On the other hand, we obtain the signed distance from OCSVM learned from the known interactions with high recall (?0.95) for each unobserved drug-target interaction. After normalizing all accumulative similarities and signed distances to the range [0,1], we compute the score for each unobserved drug-target interaction via averaging its accumulative similarity and signed distance. Unobserved interactions with lower scores are preferentially served as reliable negative samples for the classification algorithms. The performance of the proposed method is evaluated on the interaction data between 1094 drugs and 1556 target proteins. Extensive comparison experiments using four classical classifiers and one domain predictive method demonstrate the superior performance of the proposed method. A better decision boundary has been learned from the constructed reliable negative samples. CONCLUSIONS:Proper construction of highly-reliable negative samples can help the classification models learn a clear decision boundary which contributes to the performance improvement.

SUBMITTER: Zheng Y 

PROVIDER: S-EPMC6933655 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces.

Zheng Yi Y   Peng Hui H   Zhang Xiaocai X   Zhao Zhixun Z   Gao Xiaoying X   Li Jinyan J  

BMC bioinformatics 20191227 Suppl 23


<h4>Background</h4>Detection of new drug-target interactions by computational algorithms is of crucial value to both old drug repositioning and new drug discovery. Existing machine-learning methods rely only on experimentally validated drug-target interactions (i.e., positive samples) for the predictions. Their performance is severely impeded by the lack of reliable negative samples.<h4>Results</h4>We propose a method to construct highly-reliable negative samples for drug target prediction by a  ...[more]

Similar Datasets

| S-EPMC3820513 | biostudies-literature
| S-EPMC9312204 | biostudies-literature
| S-EPMC5391732 | biostudies-literature
| S-EPMC5125559 | biostudies-literature
| S-EPMC7279241 | biostudies-literature
| S-EPMC5445096 | biostudies-literature
| S-EPMC9917231 | biostudies-literature
| S-EPMC4175719 | biostudies-literature
| S-EPMC9189996 | biostudies-literature
| S-EPMC7215100 | biostudies-literature